EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160040162A1
SERIAL NO

14776533

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 53 skipping are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SAREPTA THERAPEUTICS INC215 FIRST STREET CAMBRIDGE MA 02142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BESTWICK, Richard K Corvallis, US 49 820
FRANK, Diane Elizabeth Seattle, US 23 316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation